N-(Piperidin-4-yl)-tetrahydro-2H-pyran-4-carboxamide hydrochloride, 95.0%, 1g

Ethyl 2,6-dichloronicotinate, 95.0%, 100g

Pipettenspitzen MIKRO 0,1–10 μl mit Skala, Nachfüllung, 960 Stück, unsteril, 960 Stück

4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 1g

Natronlauge 20 %, reinst, 25 l, kunststoffverpackung.

3,6-Dimethoxy-9H-carbazole, 97.0%, 10g

tert-Butyl ((trans-4-aminocyclohexyl)methyl)carbamate, 95.0%, 5g

LRRK2-IN-1, 95%, 5mg

Ethyl 2-(2-methoxy-5-nitrophenoxy)acetate, 98%, 5g

METHYL 2,6-DIFLUORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE, 95%, 1g

7-Chlorofuro[2,3-c]pyridine-5-carboxylic acid, 98%, 250mg

Dibenzo[b,d]thiophen-3-amine, 98%, 1g

n-Valeriansäure, min. 98 %, 250 ml, Glasverpackung